Molecular imaging and therapy of atherosclerosis with targeted nanoparticles

Advances in bionanotechnology are poised to impact the field of cardiovascular diagnosis and therapy for decades to come. This review seeks to illustrate selected examples of newly developed diagnostic and therapeutic nanosystems that have been evaluated in experimental atherosclerosis, thrombosis, and vascular biology. We review a variety of nanotechnologies that are capable of detecting early cardiovascular pathology, as well as associated imaging approaches and conjunctive strategies for site‐targeted treatment with nanoparticle delivery systems. J. Magn. Reson. Imaging 2007. © 2007 Wiley‐Liss, Inc.

[1]  Craig J. Hawker,et al.  The Convergence of Synthetic Organic and Polymer Chemistries , 2005, Science.

[2]  S. Schmitz,et al.  Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. , 2000, Investigative radiology.

[3]  A. Haase,et al.  Fast 19F-NMR imaging in vivo using FLASH-MRI. , 1994, Magnetic resonance imaging.

[4]  Vasilis Ntziachristos,et al.  In Vivo Imaging of Proteolytic Activity in Atherosclerosis , 2002, Circulation.

[5]  J. Werkmeister,et al.  MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[6]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[7]  Samuel A Wickline,et al.  Targeted contrast agents for magnetic resonance imaging and ultrasound. , 2005, Current opinion in biotechnology.

[8]  Patrick Winter,et al.  Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Leon Hirsch,et al.  Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer , 2004, Technology in cancer research & treatment.

[10]  Grace Hu,et al.  Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.

[11]  M. Ferrari,et al.  Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. , 2003, Circulation.

[12]  J. G. Miller,et al.  In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. , 1998, The Journal of the Acoustical Society of America.

[13]  P. Shah,et al.  Role of inflammation and metalloproteinases in plaque disruption and thrombosis , 1998, Vascular medicine.

[14]  Shuming Nie,et al.  Quantum dot-encoded beads. , 2005, Methods in molecular biology.

[15]  S. Wickline,et al.  Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model , 2002, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[16]  Jeff W M Bulte,et al.  Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques , 2003, Transplantation.

[17]  J. G. Miller,et al.  In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[18]  S. Mousa,et al.  Alpha(v)beta(3) integrin in angiogenesis and restenosis. , 2001, Drug news & perspectives.

[19]  D. P. O'Neal,et al.  Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.

[20]  V. Fuster,et al.  Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging , 2004, Circulation.

[21]  Ralph Weissleder,et al.  Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers , 2005, Chembiochem : a European journal of chemical biology.

[22]  Jamey P Weichert,et al.  Imaging of murine liver tumor using microCT with a hepatocyte-selective contrast agent: accuracy is dependent on adequate contrast enhancement. , 2004, The Journal of surgical research.

[23]  Harvey R Herschman,et al.  Molecular Imaging: Looking at Problems, Seeing Solutions , 2003, Science.

[24]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[25]  L. Petit,et al.  Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[26]  D. McPherson,et al.  In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. , 1999, Journal of the American College of Cardiology.

[27]  S James Adelstein,et al.  Molecular targeting with radionuclides: state of the science. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[28]  E. Ritman,et al.  Simvastatin Preserves the Structure of Coronary Adventitial Vasa Vasorum in Experimental Hypercholesterolemia Independent of Lipid Lowering , 2002, Circulation.

[29]  R Weissleder,et al.  Targeted contrast agents in MR imaging. , 1996, Magnetic resonance imaging clinics of North America.

[30]  J. Debatin,et al.  Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.

[31]  S. Wickline,et al.  Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. , 1997, Circulation.

[32]  René M. Botnar,et al.  Molecular Magnetic Resonance Imaging of Atrial Clots in a Swine Model , 2005, Circulation.

[33]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[34]  Eric T Ahrens,et al.  In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.

[35]  Erkki Ruoslahti,et al.  Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Bachilo,et al.  Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. , 2004, Journal of the American Chemical Society.

[37]  Rika Takikawa,et al.  [In-vivo visualization of gene expression using magnetic resonance imaging]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[38]  S. Mousa,et al.  Selective alpha(v)beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. , 2001, Circulation.

[39]  Shelton D Caruthers,et al.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. , 2003, Cancer research.

[40]  Ralph Weissleder,et al.  Magnetic relaxation switches capable of sensing molecular interactions , 2002, Nature Biotechnology.

[41]  René M. Botnar,et al.  In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent , 2004, Circulation.

[42]  P. Constantinides,et al.  Plaque fissures in human coronary thrombosis , 1966 .

[43]  Samuel A Wickline,et al.  Sonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug delivery. , 2005, Ultrasound in medicine & biology.

[44]  Wadih Arap,et al.  Design and validation of a bifunctional ligand display system for receptor targeting. , 2004, Chemistry & biology.

[45]  Alexander Petrovsky,et al.  Oligomerization of Paramagnetic Substrates Result in Signal Amplification and Can be Used for MR Imaging of Molecular Targets , 2002, Molecular imaging.

[46]  J. Hamers,et al.  [Methods and techniques]. , 1997, Verpleegkunde.

[47]  Raymond C. Boston,et al.  Dynamic Imaging of Allogeneic Mesenchymal Stem Cells Trafficking to Myocardial Infarction , 2005, Circulation.

[48]  M. Bednarski,et al.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.

[49]  Jeff W M Bulte,et al.  Monitoring cell therapy using iron oxide MR contrast agents. , 2004, Current pharmaceutical biotechnology.

[50]  S. Bachilo,et al.  Versatile visualization of individual single-walled carbon nanotubes with near-infrared fluorescence microscopy. , 2005, Nano letters.

[51]  T Suzuki,et al.  Considerable Time From the Onset of Plaque Rupture and/or Thrombi Until the Onset of Acute Myocardial Infarction in Humans: Coronary Angiographic Findings Within 1 Week Before the Onset of Infarction , 2000, Circulation.

[52]  Ergin Atalar,et al.  In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.

[53]  H. Harashima,et al.  Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[54]  Bruno Brochet,et al.  Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging , 2004, Investigative radiology.

[55]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[56]  M. Corjay,et al.  αvβ3, αvβ5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation , 1999 .

[57]  S A Wickline,et al.  Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.

[58]  P R Bell,et al.  Angiogenesis and the atherosclerotic carotid plaque: association between symptomatology and plaque morphology , 1999, Journal of vascular surgery.

[59]  F. Blankenberg,et al.  Noninvasive strategies to image cardiovascular apoptosis. , 2001, Cardiology clinics.

[60]  M A Konerding,et al.  Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.

[61]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[62]  Martin J Graves,et al.  In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI , 2004, Stroke.

[63]  R. Zhou,et al.  MR and fluorescent imaging of low-density lipoprotein receptors. , 2004, Academic radiology.

[64]  R. Virmani,et al.  Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel , 2002, Circulation.

[65]  George A. Mensah,et al.  Sudden Cardiac Death in the United States, 1989 to 1998 , 2001, Circulation.

[66]  S A Wickline,et al.  Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. , 2000, Magnetic resonance in medicine.

[67]  A. Newby,et al.  Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.

[68]  J. G. Miller,et al.  A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.

[69]  R E Jacobs,et al.  A model for MRI contrast enhancement using T1 agents. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Yixia Zhang,et al.  Immunohistochemical study of intimal microvessels in coronary atherosclerosis. , 1993, The American journal of pathology.

[71]  R. Stafford,et al.  Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[72]  John M Pauly,et al.  Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles , 2005, Magnetic resonance in medicine.

[73]  Shelton D Caruthers,et al.  Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.

[74]  Lynn W. Jelinski,et al.  Nuclear magnetic resonance spectroscopy. , 1990, Analytical chemistry.

[75]  Susannah H Bloch,et al.  Radiation-Force Assisted Targeting Facilitates Ultrasonic Molecular Imaging , 2004, Molecular imaging.

[76]  R. Weissleder,et al.  Molecular Imaging of Factor XIIIa Activity in Thrombosis Using a Novel, Near-Infrared Fluorescent Contrast Agent That Covalently Links to Thrombi , 2004, Circulation.

[77]  Patrick J. Gaffney,et al.  Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .

[78]  F. Sarkar,et al.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. , 1995, The Journal of clinical investigation.

[79]  L W Jelinski,et al.  Nuclear magnetic resonance spectroscopy. , 1995, Academic radiology.

[80]  Jeff W M Bulte,et al.  Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. , 2003, Radiology.

[81]  M. Strano,et al.  Near-infrared optical sensors based on single-walled carbon nanotubes , 2004, Nature materials.

[82]  J. Isner,et al.  Cancer and atherosclerosis: the broad mandate of angiogenesis. , 1999, Circulation.

[83]  Kerry K. Karukstis,et al.  Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.

[84]  M. E. Kooi,et al.  Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.

[85]  Shelton D Caruthers,et al.  In Vitro Demonstration Using 19F Magnetic Resonance to Augment Molecular Imaging With Paramagnetic Perfluorocarbon Nanoparticles at 1.5 Tesla , 2006, Investigative radiology.

[86]  Shelton D Caruthers,et al.  Molecular imaging of human thrombus with computed tomography. , 2005, Academic radiology.

[87]  Shelton D Caruthers,et al.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. , 2003, Circulation.

[88]  Stasia A. Anderson,et al.  Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .

[89]  Trevor Douglas,et al.  Paramagnetic viral nanoparticles as potential high‐relaxivity magnetic resonance contrast agents , 2005, Magnetic resonance in medicine.

[90]  J. Goldstein.  Multifocal coronary plaque instability. , 2002, Progress in cardiovascular diseases.

[91]  S. Simon,et al.  AUGMENTED AND SELECTIVE DELIVERY OF LIQUID PERFLUOROCARBON NANOPARTICLES TO MELANOMA CELLS WITH NONCAVITATIONAL ULTRASOUND , 2003 .

[92]  D. McPherson,et al.  Left Ventricular Thrombus Enhancement After Intravenous Injection of Echogenic Immunoliposomes: Studies in a New Experimental Model , 2002, Circulation.

[93]  Kejia Cai,et al.  Targeted PARACEST nanoparticle contrast agent for the detection of fibrin , 2006, Magnetic resonance in medicine.

[94]  M. Doyle,et al.  Chemical‐shift imaging: A hybrid approach , 1987, Magnetic resonance in medicine.

[95]  S. Caruthers,et al.  1054-155 Antiangiogenic therapy of early atherosclerosis with paramagnetic ανβ3-integrin-targeted fumagillin nanoparticles , 2004 .

[96]  Samuel A Wickline,et al.  Targeted ultrasonic contrast agents for molecular imaging and therapy. , 2001, Current problems in cardiology.

[97]  A. Becker,et al.  Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? , 1999, Cardiovascular research.

[98]  Ying Yu,et al.  c-Jun Decreases Voltage-Gated K+ Channel Activity in Pulmonary Artery Smooth Muscle Cells , 2001, Circulation.

[99]  K. Peters,et al.  Neovascularization in atherectomy specimens from patients with unstable angina: implications for pathogenesis of unstable angina. , 1998, American heart journal.

[100]  S. Caruthers,et al.  Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. , 2004, Current pharmaceutical biotechnology.

[101]  M. Corjay,et al.  alphavbeta3, alphavbeta5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formation. , 1999, Journal of cellular biochemistry.

[102]  Samuel A Wickline,et al.  Nanotechnology for molecular imaging and targeted therapy. , 2003, Circulation.

[103]  Roger Y Tsien,et al.  Imagining imaging's future. , 2003, Nature reviews. Molecular cell biology.

[104]  Hisataka Kobayashi,et al.  Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. , 2003, Bioconjugate chemistry.

[105]  F. Hennrich,et al.  Spectroscopy of single- and double-wall carbon nanotubes in different environments. , 2005, Nano letters.

[106]  René M. Botnar,et al.  Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. , 2005, American journal of respiratory and critical care medicine.

[107]  M. Brechbiel,et al.  Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores , 2001, Magnetic resonance in medicine.

[108]  Zahi A Fayad,et al.  Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.

[109]  Kai Qi,et al.  64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[110]  Ralph Weissleder,et al.  A fluorescent nanosensor for apoptotic cells. , 2006, Nano letters.

[111]  Samuel A Wickline,et al.  Molecular imaging, targeted therapeutics, and nanoscience , 2002, Journal of cellular biochemistry. Supplement.

[112]  D. McPherson,et al.  Intravascular ultrasound molecular imaging of atheroma components in vivo. , 2004, Journal of the American College of Cardiology.

[113]  R. Virmani,et al.  Sudden cardiac death. , 1987, Human pathology.

[114]  C. Hoeller,et al.  MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. , 2004, Magnetic resonance imaging.